Ad is loading...
LMVVX
Price
$32.58
Change
-$0.27 (-0.82%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

LMVVX vs VISVX

Header iconLMVVX vs VISVX Comparison
Open Charts LMVVX vs VISVXBanner chart's image
Lord Abbett Focused Small Cap Value R5
Price$32.58
Change-$0.27 (-0.82%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
LMVVX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMVVX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVVX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. LMVVX (107M). VISVX pays higher dividends than LMVVX: VISVX (1.90) vs LMVVX (0.23). LMVVX was incepted earlier than VISVX: LMVVX (5 years) vs VISVX (27 years). LMVVX is a more actively managed with annual turnover of: 54.00 vs. VISVX (16.00). LMVVX has a lower initial minimum investment than VISVX: LMVVX (0) vs VISVX (3000). VISVX (28.71) and LMVVX (28.56) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. LMVVX (16.28).
LMVVXVISVXLMVVX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years27 years-
Gain YTD14.11615.43391%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets107M57.6B0%
Annual Yield % from dividends0.231.9012%
Returns for 1 year28.5628.7199%
Returns for 3 years-6.0713.23-46%
Returns for 5 years16.2857.3228%
Returns for 10 yearsN/A108.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics